Physician profile
William Kim
NPI 1144228628
$163,986.76
in general payments reported to CMS, 2019-2025
20 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,819 · 2020: $1,211 · 2021: $157K · 2022: $4,025 · 2023: $87.42 · 2024: $19.38 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $129,766.40 | 2019-2021 | |
| Johnson & Johnson Health Care Systems INC. | $26,422.00 | 2021 | |
| Arthrex, INC. | $5,165.38 | 2021-2022 | |
| Advanced Orthopaedic Solutions, INC. | $1,665.83 | 2019-2020 | |
| Stryker Corporation | $227.70 | 2021-2025 | Gamma |
| Zimmer Biomet Holdings, INC. | $166.94 | 2019 | |
| Henry Schein, INC. | $126.52 | 2022 | |
| Depuy Synthes Sales INC. | $96.69 | 2020-2025 | Orthovisc, Monovisc |
| Covidien Lp | $91.59 | 2019 | |
| Merck Sharp & Dohme LLC | $56.65 | 2022-2025 | |
| Ferring Pharmaceuticals INC. | $33.75 | 2019 | |
| Convatec INC. | $30.46 | 2023 | |
| Bioventus LLC | $21.94 | 2025 | Exogen Ultrasound Bone Healing System |
| Ultragenyx Pharmaceutical INC. | $20.99 | 2021 | |
| Sanofi Pasteur INC. | $19.71 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $19.38 | 2024 | |
| Smith+Nephew, INC. | $18.88 | 2023 | Trigen Intertan |
| Relievant Medsystems, INC. | $16.64 | 2023 | Intracept |
| Horizon Therapeutics Plc | $14.33 | 2019 | |
| Electronic Waveform Lab, INC. | $4.98 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.